Niga-ichigoside F1

CAS : 95262-48-9

Ref. 3D-VDA26248

Informations sur le produit

• Nom: Niga-ichigoside F1
• Synonymes: 19α-Hydroxyasiatic acid 28-O-β-<span class="text-smallcaps">D</span>-glucopyranoside, 19α-Hydroxyasiatic acid β-<span class="text-smallcaps">D</span>-glucopyranosyl ester, Dotorioside II, DotoriosideII, Laevigatanoside A, Niga-ichigoside F 1, Urs-12-en-28-oic acid, 2,3,19,23-tetrahydroxy-, β-<span class="text-smallcaps">D</span>-glucopyranosyl ester, (2α,3β,4α)-

Description

Niga-ichigoside F1 is an antidiabetic agent that is extracted from the bark of a tree in the genus Niga. It has been shown to decrease the blood glucose level by increasing the production of insulin, suppressing gluconeogenesis, and inhibiting glycogenolysis. Niga-ichigoside F1 also contains triterpenoid saponins that are known to have anti-inflammatory properties. This drug has been used as a treatment for various types of cancer, such as skin cancer and breast cancer. Niga-ichigoside F1 may also be beneficial in preventing cisplatin-induced nephrotoxicity and hepatic steatosis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 666.8 g/mol
• Formule: C₃₆H₅₈O₁₁
• Degré de pureté: Min. 95%